The Global Oncology Market is expected to grow strongly through 2032, driven by rising global cancer incidence, advances in early detection, and innovation in treatments such as immunotherapy, targeted therapies, and CAR‑T cell therapies. Precision oncology powered by AI-driven diagnostics and liquid biopsy is reshaping clinical care. North America currently leads in market share, whi... https://www.uniprismmarketresearch.com/verticals/healthcare/oncology